Predictors of early hospice or death in patients with inoperable lung cancer treated with curative intent

Predictors of early hospice or death in patients with inoperable lung cancer treated with curative intent
Clin Lung Cancer, by Siddharth Ramanathan, Kimberly A Hochstedler, Anna M Laucis, Benjamin Movsas, Craig W Stevens, Larry L Kestin, Michael M Dominello, Inga S Grills, Martha Matuszak, James Hayman, Peter A Paximadis, Matthew J Schipper, Shruti Jolly, Thomas P Boike; Michigan Radiation Oncology Quality Consortium; NCBI published 1/31/24
Introduction: Treatment for inoperable stage II to III non-small cell lung cancer (NSCLC) involves chemo-radiotherapy (CRT). However, some patients transition to hospice or die early during their treatment course. We present a model to prognosticate early poor outcomes in NSCLC patients treated with curative-intent CRT.